妇科手术后急性疼痛的阿片类药物处方使用与持续性阿片类药物使用:一项系统综述
该系统综述检索MEDLINE、EMBASE和ClinicalTrials.gov至2020年10月,纳入36项研究(37篇文章),评估良性指征妇科手术后患者阿片类药物用量及持续性阿片使用发生率。出院后14天平均使用54.0 MME(95%CI 39.9-68.0,相当于7片5mg羟考酮),持续性阿片使用约4.4%,但异质性高。
要点
- 良性指征妇科大手术后出院2周内平均使用相当于15片或更少5mg羟考酮。
- 出院后14天平均MME:经阴道子宫切除35.0,腹腔镜子宫切除59.5,开腹子宫切除108.1。
- 持续性阿片使用约4.4%,但异质性高,源于人群和结局定义差异。
核心结论
- 良性指征妇科大手术后出院2周内,患者平均使用相当于15片或更少5mg羟考酮(或等效药物)。
- 良性指征妇科手术后持续性阿片使用发生率为4.4%。
- 研究结果可帮助外科医生减少过度处方并减少药物转用或误用。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE和ClinicalTrials.gov从建库至2020年10月。
- 纳入36项研究(37篇文章),从35项研究中提取数据;23项研究包含出院后阿片消耗量数据,12项研究包含妇科手术后持续性阿片使用数据。
- 两名评价者独立筛选文献并提取合格研究的数据。
- 系统综述注册号:PROSPERO CRD42020146120。
主要发现
- 所有妇科手术类型出院后14天平均使用MME为54.0(95%CI 39.9-68.0,相当于7片5mg羟考酮)。
- 经阴道子宫切除后出院后14天平均使用MME为35.0(95%CI 0-75.12,相当于4.5片5mg羟考酮)。
- 腹腔镜子宫切除后出院后14天平均使用MME为59.5(95%CI 44.4-74.6,相当于8片5mg羟考酮)。
- 开腹子宫切除后出院后14天平均使用MME为108.1(95%CI 80.5-135.8,相当于14.5片5mg羟考酮)。
- 非子宫切除腹腔镜手术后出院24小时内平均使用MME为22.4(95%CI 12.4-32.3,相当于3片5mg羟考酮);脱垂手术后出院至出院后7或14天平均使用MME为79.8(95%CI 37.1-122.6,相当于10.5片5mg羟考酮)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 持续性阿片使用结局异质性高,源于人群和结局定义的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the amount of opioid medication used by patients and the prevalence of persistent opioid use after discharge for gynecologic surgery for benign indications. DATA SOURCES: We systematically searched MEDLINE, EMBASE, and ClinicalTrials.gov from inception to October 2020. METHODS OF STUDY SELECTION: Studies with data on gynecologic surgical procedures for benign indications and the amount of outpatient opioids consumed, or the incidence of either persistent opioid use or opioid-use disorder postsurgery were included. Two reviewers independently screened citations and extracted data from eligible studies. TABULATION, INTEGRATION, AND RESULTS: Thirty-six studies (37 articles) met inclusion criteria. Data were extracted from 35 studies; 23 studies included data on opioids consumed after hospital discharge, and 12 studies included data on persistent opioid use after gynecologic surgery. Average morphine milligram equivalents (MME) used in the 14 days after discharge were 54.0 (95% CI 39.9-68.0, seven tablets of 5-mg oxycodone) across all gynecologic surgery types, 35.0 (95% CI 0-75.12, 4.5 tablets of 5-mg oxycodone) after a vaginal hysterectomy, 59.5 (95% CI 44.4-74.6, eight tablets of 5-mg oxycodone) after laparoscopic hysterectomy, and 108.1 (95% CI 80.5-135.8, 14.5 tablets of 5-mg oxycodone) after abdominal hysterectomy. Patients used 22.4 MME (95% CI 12.4-32.3, three tablets of 5-mg oxycodone) within 24 hours of discharge after laparoscopic procedures without hysterectomy and 79.8 MME (95% CI 37.1-122.6, 10.5 tablets of 5-mg oxycodone) from discharge to 7 or 14 days postdischarge after surgery for prolapse. Persistent opioid use occurred in about 4.4% of patients after gynecologic surgery, but this outcome had high heterogeneity due to variation in populations and definitions of the outcome. CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.
引用
- Matteson KA, Schimpf MO, Jeppson PC, et al. Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review. Obstet Gynecol. 2023. PMID: 36897135. doi:10.1097/AOG.0000000000005104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。